http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1924587-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5eabe128c2dfe0a75d7a45c8a9203b2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6506
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
filingDate 2006-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03e03283553b35f1e65f4882a966504c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4edd0207cd0fce7f2cb3ad02ffba6d28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d4d9626140a9433918d0030c162a1bf
publicationDate 2008-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1924587-A1
titleOfInvention A crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it
abstract This invention refers to a new crystalline form of the Zoledronic acid, characterized by its X-rays diffractogram as well as by its spatial atomic distribution in the red crystalline and its curves of thermal analysis. There is also included a method to obtain this crystalline form, which includes the synthesis of the corresponding acid and the pharmaceutical composition this crystalline form comprises.
priorityDate 2005-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128806596

Total number of triples: 21.